Insight Conference
Professor of Psychiatry and Behavioral Sciences

Prof. Dr. Matthew Johnson

Johns Hopkins University, Center for Psychedelic & Consciousness Research

Matthew W. Johnson, Ph.D., is an expert on psychoactive drugs and addiction. For 15 years he has conducted psychedelic research. He has published >100 manuscripts, with 42 focused on psychedelics. Matt published psychedelic administration safety guidelines in 2008, the first research investigating psychedelic treatment of tobacco/nicotine addiction in 2014, and the largest study of psilocybin in treating cancer distress in 2016. His recent review of psilocybin abuse liability recommended its placement in Schedule IV upon medical approval. He has guided >100 psychedelic sessions. Matt has been interviewed by the BBC, New York Times, Washington Post, CNN, and Wall Street Journal.


Psychedelics as a Treatment for Alcohol use Disorder: Insights from Preclinical Models

Alcohol-dependent patients commonly show impairments in executive functions that facilitate cravi…

View Event

Conference Presentations

INSIGHT 2019: Therapeutic Effects of Psilocybin
Mapping the Mind 2019: Therapeutic and Behavioral Effects of Psychedelics

Insight Newsletter

Sign up to our newsletters and we’ll keep you up to date with everything to do with INSIGHT.